原发性乳腺血管肉瘤(primary breast angiosarcoma,PBA)及卵巢血管肉瘤均为罕见的、具有高度侵袭性和转移潜力的肿瘤,临床上同时罹患以上两种肿瘤的病例极为罕见。以上两种肿瘤在临床上均无明显特征性表现,容易发生漏诊、误诊。为帮助...
详细信息
原发性乳腺血管肉瘤(primary breast angiosarcoma,PBA)及卵巢血管肉瘤均为罕见的、具有高度侵袭性和转移潜力的肿瘤,临床上同时罹患以上两种肿瘤的病例极为罕见。以上两种肿瘤在临床上均无明显特征性表现,容易发生漏诊、误诊。为帮助临床医生早期诊断此病,现回顾性分析2023年8月收入暨南大学附属第一医院的经手术病理证实的1例PBA患者的临床资料及超声表现。该患者术后4个月经阴道超声发现左侧卵巢肿物,术后病理提示为成熟囊性畸胎瘤合并血管肉瘤。本文亦提及卵巢血管肉瘤的二维超声图像及彩色多普勒超声图像特点,并结合文献进行总结、归纳。
乳腺癌居女性恶性肿瘤发病率的第1位,人类表皮生长因子受体2 (human epiderma growth factor receptor-2, HER-2)过表达型的患者病情进展迅速,易发生淋巴结、骨骼、脑等多器官转移。本文回顾性分析1例临床分期为T4N1M0的HER-2过表达型乳腺癌患者,新辅助化疗、靶向治疗后行乳腺癌根治术,术后病理分期为ypTisN0M0,后行化疗、靶向及放疗,观察其疗效,并回顾分析相关文献。该患者随诊至今暂无转移复发。Breast cancer ranks the first place in the incidence of female malignant tumors. Patients with HER-2 over-expressing breast cancer progress rapidly, and lymph node, bone, brain and other organs are prone to metastasis. A case of HER-2 over-expressing breast cancer with clinical stage of T4N1M0 was retrospectively analyzed. After neoadjuvant chemotherapy and targeted therapy, modified radical mastectomy was performed. The pathological stage was ypTisN0M0, and then followed by chemotherapy, targeted therapy and radiotherapy. The patient has no metastasis or recurrence.
暂无评论